Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine

This article was originally published in PharmAsia News

Executive Summary

An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry

You may also be interested in...



Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the 32nd annual Goldman Sachs Global Healthcare Conference ('Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference,' PharmAsia News, June 15, 2011). For this profile, we zoom in on the Morgan Stanley Global Healthcare Conference, held Sept. 13-14 in New York.

Regulatory And Staffing Challenges For Private Hospitals In Southeast Asia - Private Healthcare World Asia 2011

SINGAPORE - Investor interest in Asia's private hospital infrastructure remains strong but regulatory limitation and lack of professional staff stymies its huge potential, industry experts told a Singapore conference June 15

Beyond BRIC: 'Pharmerging' Markets Loom If Pharma Is To Expand, IMS Study Says

Drug makers need to more aggressively target so-called "pharmerging" markets - but not just the usual suspects. Brazil, Russia, India and China remain highly important, but in a March 16 report, IMS Health predicts that 17 countries, in total, will contribute 48 percent of annual market growth in 2013, up from 37 percent last year

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC079148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel